·   Log in

Archive for April 6th, 2010

Insulin cell implant Diabecell for type 1 diabetes to go on human studies in New Zealand

Tuesday, April 6, 2010 22:11

Diabecell, encapsulated insulin-producing cells to be implanted into the abdomen of patients developed by Living Cell Technologies Limited, has been granted approval for phase 2 human trials in New Zealand.

This was posted under category: Biotech  |  Read Full Story  |  1 Comment

Daiichi seeks Japanese approval for once-daily blood clotting pill Edoxaban

Tuesday, April 6, 2010 18:56

Edoxaban, an investigative once-daily oral factor Xa inhibitor to arrest blood clotting, has been submitted for approval in Japan by Daiichi Sankyo.

This was posted under category: Pharma  |  Read Full Story  |  0 Comments

Biodegradable patch TachoSil to control surgical bleeding to hit US market

Tuesday, April 6, 2010 18:52

TachoSil, an absorbable fibrin sealant patch for use in cardiovascular surgery to prevent mild and moderate bleeding from small blood vessels, has been approved in US.

This was posted under category: medical devices  |  Read Full Story  |  0 Comments
Tagged with: ,

Parexel launches e-clinical solutions platform for late phase trials

Tuesday, April 6, 2010 16:44

Parexel International Corporation, a leading global biopharmaceutical services provider, has introduced a new web-based technology platform for late phase clinical research for the biopharmaceutical industry.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with:

Inhaled ciprofloxacin to treat bronchiectasis from Aradigm may hit markets soon

Tuesday, April 6, 2010 10:17

Inhaled ciprofloxacin for the treatment of bronchiectasis is currently in clinical trails, Aradigm announced.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments

Indian firms stand to gain as US generic market is forecast to grow at a CAGR of around 9% during 2010-2012

Tuesday, April 6, 2010 6:51

The generic drugs market in the world's biggest pharmaceuticals market US is anticipated to grow at a CAGR of around 9% during 2010-2012 even as India companies line up to grab a considerable share of the business.

This was posted under category: Industry  |  Read Full Story  |  0 Comments

Cobalamin-based oral insulin by Access for diabetes type 2 is coming

Tuesday, April 6, 2010 6:47

Access Pharma is currently developing cobalamin-based oral insulin to treat type 2 diabetes, the company announced.

This was posted under category: health  |  Read Full Story  |  0 Comments